Renal Sympathetic Denervation for Reduction of Pain and Improvement of Insulin Sensitivity in Adult Polycystic Kidney Disease

Not Applicable

• Conditions: Adult Polycystic Kidney Disease

• Registration Number: NCT02062671
• Lead Sponsor: Odense University Hospital

Brief Summary

In patients with polycystic kidney disease, pain may be resistant to drug therapy and may reduce quality of life. This study investigate the effect of renal denervation on this pain.

Detailed Description

Not available

Study Timeline

• Status Verified: 2014-02
• Study Start: 2014-02
• Study First Submitted: 2014-02-12
• Study First Submitted QC: 2014-02-13
• Last Update Submitted: 2014-02-13
• Study First Posted: 2014-02-14
• Last Update Posted: 2014-02-14
• Primary Completion: 2015-02
• Study Completion: 2015-02

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 12

Inclusion Criteria

• Pain limiting daily activities in spite of pain killers, ADPKD

Exclusion Criteria

• Pregnancy

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: CROSSOVER

Primary Outcome Measures

Name	Time	Method
Pain	6 months	Pain from VAS

Secondary Outcome Measures

Name	Time	Method
Quality of Life (QoL)	6 months	SF-12v2

Trial Locations

Locations (1)

Department of Nephrology; 🇩🇰 Odense, Denmark